Company intelligence / Profile preview

Vaporsens

Salt Lake City, Utah, United Statesrocketreach.co ↗

Ownership: Private
Employees: ~28
Development stage: Commercial

Overview

Developed and commercialized nanofiber-based sensors capable of detecting trace airborne chemicals with high sensitivity and selectivity. Applications included law enforcement explosive/narcotic detection and indoor air quality monitoring. Acquired by Gentex in 2020 for $10.5M after demonstrating market traction in multiple sectors.

Therapeutic areas: OtherPulmonologyNeurology
Modalities: DeviceNanofiber-based sensor technology
Industry: Non-Drug Biotech

Partnerships

University of Utah (spinout origin)

Beyond the preview

Go deeper on Vaporsens.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaporsens.

Explore the full profile